Ageusia as a Manifestation of Long Covid

Abstract

We define "Long-COVID" as that phase of the disease following SARS-Cov2 infection which clinically continues for months after infection. It is considered to affect approximately 1 in 10 patients. Long-COVID presents a very broad and heterogeneous clinical picture that ranges from general manifestations such as fatigue and malaise to both central and peripheral neurological symptoms, from cardiovascular manifestations to ENT symptoms, from gastrointestinal symptoms to musculoskeletal manifestations. In this work, through a concise review of the literature, we have focused attention on the etiopathogenetic and clinical aspects of ageusia, one of the most frequent and important consequences of long-COVID.